The ex-head of Novartis’ global antitrust practice, and having worked at the company for more than a decade, Ms Jones has overseen a series of “high-profile transformational deals”, according to Gilbert + Tobin, including the GSK and Lilly merger clearances and the recent sale of its Sandoz division’s dermatology business and generic assets to Aurobindo.

Prior to her Novartis work, Ms Jones held a senior associate role with Allen & Overy in Brussels, and has also been a senior investigator at the Australian Competition and Consumer Commission, a statement said.

“I’m excited to join Gilbert + Tobin, which has a strong reputation in competition law and a great team that has a culture of collaboration, innovation, performance and client service,” Ms Jones said.

“I’m also impressed by Gilbert + Tobin’s high proportion of female partners and a commitment to good corporate citizenship,” she continued.

Head of the competition and regulation practice Luke Woodward said they are “delighted to welcome Susan who will be a great fit for the firm”.

“The appointment will further enhance the competition group and in particular, the Melbourne team,” he noted.

“Susan’s expertise in the health and life sciences sector, building on the firm’s strong expertise and experience in this strategically important sector, will contribute significantly to the group’s reputation in high-stakes competition and regulation matters,” Mr Woodward continued.

VIEW ALL

This email address is being protected from spambots. You need JavaScript enabled to view it.